Stockscreener 앱 받기
2.56
3.40%
-0.09
전일 마감가:
$2.65
열려 있는:
$2.61
하루 거래량:
79,344
Relative Volume:
1.21
시가총액:
$20.18M
수익:
$2.34M
순이익/손실:
$-30.37M
주가수익비율:
-0.87
EPS:
-2.9424
순현금흐름:
$-23.42M
1주 성능:
-8.57%
1개월 성능:
-40.47%
6개월 성능:
-47.76%
1년 성능:
-48.95%
1일 변동 폭
$2.45
$2.6888
1주일 범위
$2.45
$2.9354
52주 변동 폭
$2.45
$16.25
Radiopharm Theranostics Ltd Adr Stock (RADX) Company Profile
Compare RADX vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RADX
Radiopharm Theranostics Ltd Adr
|
2.56 | 21.92M | 2.34M | -30.37M | -23.42M | -2.9424 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Radiopharm Theranostics Ltd Adr Stock (RADX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-12 | 개시 | B. Riley Securities | Buy |
Radiopharm Theranostics Ltd Adr 주식(RADX)의 최신 뉴스
Radiopharm Theranostics (RADX) seeks shareholder approval for placements, SPP and new warrants - Stock Titan
Radiopharm stock tumbles 21% on dilutive capital raise By Investing.com - Investing.com Nigeria
Radiopharm Theranostics Raises A$12.5 Million in Institutional Capital as RAD101 Phase 3 Trial Nears Commencement - Kalkine
Radiopharm Theranostics Reports Positive Results from RAD204 and RAD101 Trials - smallcaps.com.au
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and Santhera Pharmaceuticals Holding (OtherSPHDF) - The Globe and Mail
Radiopharm Theranostics Limited Financial Disclosures & SEC Filings - TradingView
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Biomea Fusion (BMEA) and Senseonics Holdings (SENS) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX), TScan Therapeutics (TCRX) and PACS Group Inc (PACS) - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Ascentage Pharma Group International (HK:6855), Kiora Pharmaceuticals (KPRX) - The Globe and Mail
Radiopharm Theranostics stock initiated with buy rating at H.C. Wainwright - Investing.com
RADXRadiopharm Theranostics Ltd ADR Stock Price and Quote - Finviz
Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI), Immunic (IMUX) and Protara Therapeutics (TARA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Definium Therapeutics (DFTX) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Protara Therapeutics (TARA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT) and TriSalus Life Sciences (TLSI) - The Globe and Mail
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - The Manila Times
Radiopharm Theranostics Highlights Phase 1 Pipeline, Eyes June RAD 101 Data at DB Conference - Yahoo Finance
RAD: Multiple first-in-class radiopharmaceuticals advance in parallel, with key data readouts expected soon - TradingView
RAD: Multiple phase I trials and an imaging agent drive near-term catalysts and long-term value - TradingView
Radiopharm Theranostics ADR (RADX): Inside the Clinical Programs - Yahoo Finance
Unusual VolumeStock ScreenerNews - Finviz
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026 - The Manila Times
Radiopharm Theranostics (NASDAQ: RADX) faces 1.29-quarter cash runway - Stock Titan
Radiopharm Theranostics Reports Business Update - GlobeNewswire Inc.
Analysts’ Top Healthcare Picks: Perspective Therapeutics (CATX), Nektar Therapeutics (NKTR) - The Globe and Mail
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026 - Yahoo Finance
Analysts’ Top Healthcare Picks: Rapport Therapeutics, Inc. (RAPP), Abbott Laboratories (ABT) - The Globe and Mail
Radiopharm Theranostics LimitedSponsored ADR (NASDAQ:RADX) Sees Significant Growth in Short Interest - MarketBeat
Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial - Yahoo Finance
Radiopharm Theranostics Taps Siemens for U.S. Supply of Fast-Tracked Brain Metastases Imaging Agent RAD101 - TipRanks
Analysts Offer Insights on Healthcare Companies: Jasper Therapeutics (JSPR), Alto Neuroscience, Inc. (ANRO) and Viridian Therapeutics (VRDN) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and RenovoRx (RNXT) - The Globe and Mail
Radiopharm Theranostics Doses First Patient in Phase 1 RAD 402 Prostate Cancer Trial - TipRanks
Radiopharm Theranostics Shares RAD101 Phase IIb Update: 90% Hit Primary Endpoint in Brain Mets Study - Yahoo Finance
Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Citius Oncology (CTOR) and Oruka Therapeutics (ORKA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Sana Biotechnology (SANA) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Shattuck Labs (STTK) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Ocugen (OCGN) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Atai Beckley N.V. (ATAI) - The Globe and Mail
Radiopharm Theranostics Doses First Patient in Phase 1/2a Trial of 177Lu-BetaBart - TipRanks
Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Beyond Air (XAIR) - The Globe and Mail
Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Fifth Third Bancorp (NASDAQ:FITB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Hartford Multifactor Emerging Markets ETF (NYSEARCA:ROAM) Short Interest Up 110.6% in January - Defense World
Radiopharm Theranostics Limited – Sponsored ADR (NASDAQ:RADX) Sees Significant Increase in Short Interest - Defense World
Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Expands By 112.1% - Defense World
iShares Environmentally Aware Real Estate ETF (NASDAQ:ERET) Sees Significant Increase in Short Interest - Defense World
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX) - The Globe and Mail
Radiopharm Theranostics Ltd Adr (RADX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):